Cargando…
NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A
Emerging evidences show that disruption of the circadian rhythm is associated with tumor initiation and progression. Neuronal PAS domain protein 2 (NPAS2), one of the core circadian molecules, has been proved to be a potential prognostic biomarker in colorectal and breast cancers. However, to date,...
Autores principales: | Yuan, Peng, Li, Jibin, Zhou, Feng, Huang, Qichao, Zhang, Jiansheng, Guo, Xu, Lyu, Zhuomin, Zhang, Hongxin, Xing, Jinliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386534/ https://www.ncbi.nlm.nih.gov/pubmed/28333141 http://dx.doi.org/10.1038/cddis.2017.131 |
Ejemplares similares
-
Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients
por: Yuan, Peng, et al.
Publicado: (2014) -
High leukocyte mtDNA content contributes to poor prognosis through ROS-mediated immunosuppression in hepatocellular carcinoma patients
por: He, Xianli, et al.
Publicado: (2016) -
Down-regulation of BMAL1 by MiR-494-3p Promotes Hepatocellular Carcinoma Growth and Metastasis by Increasing GPAM-mediated Lipid Biosynthesis
por: Yang, Yi, et al.
Publicado: (2022) -
Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways
por: Huang, Qichao, et al.
Publicado: (2016) -
Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation
por: Yuan, Peng, et al.
Publicado: (2021)